Pharmaceutical issue in second FTA talks

Published: 2006-07-12 06:58:00

Updated: 2006-07-12 06:58:00

The United States is working on the issue with the drug pricing based on the positive list system in the ongoing talks of the free trade agreement (FTA) with Korea, likely putting a brake on the nation's health reform.

The Korean government forecast the U.S. will demand a resolution to pricing...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK